Novo Nordisk: Competing In A Duopoly [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
NVO's future growth hinges on defending market share with new GLP-1 products, including oral Wegovy, higher-dose Wegovy, and an innovative pipeline. Despite a strong pipeline, NVO's current injectable offerings lag Eli Lilly's, and upcoming patent expirations raise sustainability concerns. I value NVO at $29 per share, below the current price, and rate it 'Hold' due to competitive pressures and limited market share gains. Victor Golmer/iStock Editorial via Getty Images Investment Thesis Novo Nordisk A/S ( NVO ) competes almost exclusively against Eli Lilly and Company ( LLY ) in a fast growing GLP-1 market. Although the falling stock price may make the company cheap, competition
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk (NVO) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S (NVO) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d+)" to "hold (c-)".MarketBeat
- Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker? [Yahoo! Finance]Yahoo! Finance
- CNBC's UK Exchange newsletter: Brace yourself for rising bills as new tax year kicks off Share [CNBC]CNBC
- Vltava Fund Q1 2026 Letter To Shareholders [Seeking Alpha]Seeking Alpha
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 4/7/26 - Form 6-K
- 3/30/26 - Form 6-K
- 3/27/26 - Form 6-K
- NVO's page on the SEC website